nivolumab,ipilimumab
bms
['ipi+', 'nivo', 'check,mate,914']
the #oncoalerttoptweet day 4 of #asco23 tweet by our faculty masterful presentation by reporting subgroup analyses from #checkmate914 (part a). exploratory analyses suggest tumor pd-l1 expression influenced outcome of adjuvant ipi+nivo 
🌐 Worldwide Network of Oncology Professionals & Patient Advocates with the common goal of ending cancer, we are Oncology360 degrees 🌎 We are #OncoAlert 🚨